Bausch Health
Sells specialty medicines, medical devices and eye-health products through Bausch + Lomb.
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Shares outstanding 373.99M · Float 331.22M · 88.6% free float
A Form 4 total here can count shares the filer formally disclaims — an award voted by proxy, for instance — which the holder's own Schedule 13D/G excludes, so where the two disagree the schedule's smaller figure is used.
Institutions13F, as of Jun 30, 2026
243 holders · 239.32M shares · 31 new positions · 105 increased · 61 reduced · 37 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Paulson & Co. Inc. | 73.26M | 19.59% | 0 | Aug 14, 2026 |
| Goldentree Asset Management LP | 34.67M | 9.27% | 0 | Aug 14, 2026 |
| Royal Bank of Canada | 10.83M | 2.90% | −530.9K | Aug 14, 2026 |
| Healthcare of Ontario Pension Plan Trust Fund | 8.00M | 2.14% | 0 | Aug 13, 2026 |
| Vanguard Capital Management LLC | 7.47M | 2.00% | +61.7K | Aug 13, 2026 |
| Goldman Sachs Group Inc | 6.23M | 1.66% | +1.02M | Aug 14, 2026 |
| MFN Partners Management, LP | 6.00M | 1.60% | 0 | Aug 12, 2026 |
| SG Americas Securities, LLC | 5.54M | 1.48% | +5.52M | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Paulson & Co. Inc. | 19.10% | 70.76M | 13D | Aug 14, 2025 ↗ |
| Alex Meruelo | 9.99% | 36.76M | 13D | Apr 7, 2025 ↗ |
| GoldenTree Asset Management LP | 9.30% | 34.25M | 13G | Aug 14, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Paulson & Co. Inc. | 10 percent owner | 70.76M | 18.92% | Nov 28, 2025 |
| Thomas Appio | director, officer: Chief Executive Officer | 2.32M | 0.62% | Mar 3, 2026 |
| Jean-Jacques Charhon | officer: EVP, CFO | 706.5K | 0.19% | Mar 3, 2026 |
| Seana Carson | officer: EVP, General Counsel | 616.8K | 0.16% | Mar 3, 2026 |
| John Paulson | director | 430.2K | 0.12% | Jul 2, 2026 |
| Aimee J. Lenar | officer: President, US Pharma | 334.9K | 0.09% | Aug 20, 2026 |
| Amy B. Wechsler | director | 315.0K | 0.08% | Jul 2, 2026 |
| Robert N. Power | director | 300.6K | 0.08% | May 26, 2026 |
| Sarah B. Kavanagh | director | 282.2K | 0.08% | May 26, 2026 |
| Steven D. Miller | director | 229.2K | 0.06% | May 20, 2025 |
1 ten-percent owner holds 70.76M shares by Form 4 — the 13D/G table above shows that stake, the figure above counts officers and directors only · 36 people have not refiled in the last 18 months (26.19M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 19, 2026 | Aimee J. Lenarofficer: President, US Pharma | Sale | 36,827 | $7.03 | 334,853 |
| May 19, 2026 | Frank D. Leedirector | Sale | 24,456 | $5.43 | 49,339 |
| Mar 3, 2026 | Seana Carsonofficer: EVP, General Counsel | Sale | 4,420 | $5.77 | 616,761 |
| Mar 2, 2026 | Seana Carsonofficer: EVP, General Counsel | Sale | 6,856 | $5.78 | 776,076 |
| Feb 27, 2026 | Seana Carsonofficer: EVP, General Counsel | Sale | 8,388 | $5.95 | 809,258 |
| Nov 25, 2025 | Paulson & Co. Inc.10 percent owner | Purchase | 2,500,000 | $6.25 | 73,255,869 |
| Sep 8, 2025 | Seana Carsonofficer: EVP, General Counsel | Sale | 13,370 | $7.31 | 499,585 |
CongressHouse and Senate disclosures
Not reported.